Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 10, Issue 4, 2007, Pages 519-536

  Su, Yaming ^a   Hu, Peidi ^a   Lee, Sung Hack ^a   Sinko, Patrick J ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; NOVOBIOCIN; TOPOTECAN; TUMOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; CELL LINE; COMPARATIVE STUDY; DOG; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; DOGS; HUMANS; INTESTINAL ABSORPTION; MALE; NEOPLASM PROTEINS; NOVOBIOCIN; RATS; RATS, SPRAGUE-DAWLEY; TOPOTECAN;

EID: 44849122024     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3qp4w     Document Type: Article

References (0)